BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26854079)

  • 1. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.
    Patel M; Oni L; Midgley A; Smith E; Tullus K; Marks SD; Jones CA; Pilkington C; Beresford MW
    Lupus; 2016 Aug; 25(9):1040-4. PubMed ID: 26854079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
    Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
    Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.
    Parodis I; Ding H; Zickert A; Arnaud L; Larsson A; Svenungsson E; Mohan C; Gunnarsson I
    Scand J Rheumatol; 2017 Jul; 46(4):263-272. PubMed ID: 27973968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.
    Ferreira GA; Teixeira AL; Calderaro DC; Sato EI
    Clin Exp Rheumatol; 2016; 34(1):42-8. PubMed ID: 26574625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus.
    Santos FM; Telles RW; Lanna CC; Teixeira AL; Miranda AS; Rocha NP; Ribeiro AL
    Lupus; 2017 Jan; 26(1):10-16. PubMed ID: 27365371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
    Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
    Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus.
    Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B
    Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant Induction of Soluble TNFR2 Compared with TNFR1 in Serum Samples of HIV Patients with or without Antiretroviral Medication.
    Sarfo B; Haile ZT; Deletsu S; Mensah EA; Bonney EY
    Infect Disord Drug Targets; 2020; 20(2):175-181. PubMed ID: 30324895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM; Farag Y; Abdelshafy M; Riad NM
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
    Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
    Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.
    Moreira JM; da Silva AN; Marciano Vieira ÉL; Teixeira AL; Kummer AM; Simões E Silva AC
    Pediatr Nephrol; 2019 Feb; 34(2):349-352. PubMed ID: 30374604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
    Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
    Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Levels of Tumor Necrosis Factor Alpha and Its Type 2 Receptor Are Elevated in Patients with Boston Type I Keratoprosthesis.
    Paschalis EI; Taniguchi EV; Chodosh J; Pasquale LR; Colby K; Dohlman CH; Shen LQ
    Curr Eye Res; 2019 Jun; 44(6):599-606. PubMed ID: 30632412
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
    Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
    Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia.
    Minuz P; Fava C; Hao S; Pedraza P; Amen G; Meneguzzi A; Vattemi G; Marini M; Zanconato G; Ferreri NR
    J Matern Fetal Neonatal Med; 2015 May; 28(8):869-75. PubMed ID: 25034210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.
    Liphaus BL; Silva SC; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Front Immunol; 2024; 15():1327255. PubMed ID: 38562920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble TNF receptors are produced at sites of inflammation and are inversely associated with self-reported symptoms (WOMAC) in knee osteoarthritis.
    Simão AP; Almeida TM; Mendonça VA; Santos SA; Gomes WF; Coimbra CC; Lacerda AC
    Rheumatol Int; 2014 Dec; 34(12):1759-63. PubMed ID: 24748490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
    Smith EMD; Jorgensen AL; Beresford MW;
    Lupus; 2017 Oct; 26(11):1212-1217. PubMed ID: 28385126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.